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Background: Accurate and timely diagnosis of endometriosis is associated with confusion. Clinical manifestations,
imaging techniques, biomarkers and surgical techniques are used as diagnostic approaches. This paper reviews
current evidence on clinical manifestation in order to help practitioners and perhaps improve women’s health.
Methods: A review of the literature on clinical diagnosis of pelvic endometriosis that appeared in the English
language biomedical journals was performed using PubMed, Science Direct and Google Scholar. The search
strategy included the combination of key words ‘endometriosis’ and ‘diagnosis’ or ‘clinical diagnosis’ in the titles
or abstracts of articles. The search included all papers published during the year 2000 to 2014. Then, the findings
were classified in order to summarize the evidence.
Results: Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement, in
all 51 papers were found relevant and included in this review. In general we found three categories of diagnostic
approaches for clinical manifestation including: i) diagnosis via symptoms obtained from history taking, ii) diagnosis via
signs obtained from physical examination and iii) diagnosis via risk factors obtained from history taking.
Conclusion: Diagnosis of endometriosis is a matter of concern. Since the disease is associated with diverse clinical
symptoms and signs, deeper and more comprehensive consideration according to patient’s history and clinical
findings is recommended for early and more accurate detection in order to prioritize women for further investigation
and contribute to its early management.Background
Endometriosis is a disease with considerable prevalence.
It has been estimated to affect 10% to 15% of women of
reproductive age [1]. The disease has several impacts in
general physical, mental, and social well-being. The an-
nual cost for hospital admission is estimated to be in a
total around 54 million euros [2]. Diagnostic delay of
endometriosis is a problematic issue [3] and it takes 8 to
11 years to be diagnosed with long and expensive diag-
nostic methods [2,4]. Thus it is essential to contemplate
diagnosis as an important topic. The best method for
early diagnosis of endometriosis is still full of unknown
issues. Research on the diagnosis of endometriosis
currently interfaces with four areas including clinical
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unless otherwise stated.surgical techniques [5]. Laparoscopy, which is consid-
ered as the golden standard in endometriosis diagnosis
has considerable risks [5], and other diagnostic methods
are presented as inaccurate and with some limitations
[6]. Therefore it seems that for developing clinical and
non-surgical approaches for early detection of disease,
effort is needed to have a better understanding of signs
and symptoms of the disease [7].
Although there are several useful overview papers on
endometriosis, most published papers are unfocused and
usually discuss about all aspects of the disease including
pathophysiology, diagnosis and treatment. While there is
not any internationally recognized noninvasive method
for diagnosis, most presurgical diagnostic methods are
clinical judgment based on medical history, symptoms
and signs [8]. Thus, this study aimed to review the litera-
ture on clinical diagnosis of endometriosis in order to
discover the clinical criteria for achieving broader andis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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endometriosis are very broad and diverse issue with a
wide range of changes [9]. Particulalrly here we focus on
current research on the history taking and physical
examination of endometriosis. It is hoped that this re-
view may help to bring more attention about clinical
diagnosis of endometriosis and consequently aid in de-




Endometriosis is defined as the presence of endometrial
tissue (gland and struma) outside the uterus [10]. Endo-
metriosis has been found in almost all of the tissues and
organs of the body [11]. In this study we focused on pel-
vic endometriosis because pelvic endometriosis is the
most common form of the disease, and it mostly affects
women during their reproductive life [12].
Search engines
The search engines included PubMed, Science Direct
and Google Scholar using the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA)
guideline [13].
Search strategy
The search strategy included the combination of key
words ‘endometriosis’ and ‘diagnosis’ or ‘clinical diagno-
sis’ in the titles or abstracts of articles.
Inclusion and exclusion criteria
All qualitative and quantitative articles in English lan-
guage biomedical journals from year 2000 to 2014 on
pelvic endometriosis were included. Case reports and ar-
ticles on non-pelvic endometriosis were excluded. The
year 2000 was chosen because the intention was to in-
clude more recent literature in this systematic review.
The initial search was carried out in January 2013 and
updated twice in March 2014 and February 2015.
Data synthesis
The findings from each idivdual paper on clinical diag-
nosis were retrieved, and were classified. Then different




A total of 2749 citations were identified and after exclu-
sion of duplicates, the abstracts of 1272 citations were
screened. Of these, 113 papers were found relevant.
However, 51 articles met inclusion criteria and were in-
cluded in this review. The study selection process isshown in Figure 1. Overall we found 16 overview/com-
mentary publications [2,9,14-27], 33 original research ar-
ticles [1,7,8,11,12,28-53], two meta-analysis [54,55] and 2
systematic reviews [56,57].Review of overview papers
A summary of overview/commentary publications is
presented in Table 1. In general, these articles focused
mainly on symptoms and treatment of the endometri-
osis. The emphasis of most papers was on pain, infertil-
ity and chronic fatigue.Clinical diagnosis
Clinical diagnosis was achieved by different approaches.
We have classified these methods in three groups:
i) clinical diagnosis by symptoms obtained from history
taking, ii) clinical diagnosis by signs obtained from phys-
ical examination and iii) clinical diagnosis by risk factors
obtained from history taking. These are summarized as
follows:Clinical diagnosis by symptoms obtained from history
taking
By taking a careful history of patients and considering
their symptoms, the disease may be greatly suspected.
Many studies recognized symptoms, which were very
common such as cyclic or perimenstrual symptoms [16].
A summary of findings on symptoms obtained from his-
tory taking are presented here:Pain Included dysmenorrhea (during and at the end of
menstruation) [2,7-9,15-17,19-26,28,29,32-37,42,53,54],
pelvic pain before and during menstruation [2,7,14,
16-18,21,23,25,33,34], and pain during sexual intercourse
or after sex (dyspareunia) [2,7-9,11,15-17,19-25]. Dyspar-
eunia was occurred only with deep thrusting [23]. Lower
abdominal pain or suprapubic pain, lower back pain
[11,14,17,20,21,29] and loin pain [17,20] were also men-
tioned. Pelvic pain was present as chronic pelvic pain
(lasting ≥6 months) and patients reported that they were
suffering from intermenstrual pain (non-period pelvic
pain) or ovulation pain [2,7,15,16,19-24,33,34,37,42].
Rectal pain was also mentioned [11,21]. Pain character
was found to be throbbing [31,35], dull or sharp and ex-
acerbated by physical activity [20]. Pain often worsened
over time and changed in character [20].Menstrual symptoms Included hypermenorrhea, men-
orrhagia, premenstrual spotting for 2–4 days [7,9,11,
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Figure 1 Study selection process.
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frequency, urinary tract infection, and cystitis [11,14,17,
18,21,23,29,32,34,36,42].
Digestive symptoms Included abdominal bloating, diar-
rhea with period, painful bowel movements and painful
defecation (dyschezia) during menses, hematochezia,
nausea and stomach upset at the time of period, consti-
pation, [11,14,16-20,22,24,25,28,29,34,35], irritable bowel
syndrome (IBS) [7,32] and early satiety [20].
Gynecologic comorbidities Included gynecological in-
fections and low resistance to infection, candidiasis
[11,29,33] infertility [2,7-9,16,17,19,21,23-25,29,34,36,37,42,45], pelvic inflammatory disease, ovarian cysts [7,32,
33] and postcoital bleeding [7].
Comorbidities Included a wide range of allergies and al-
lergic disease, dizziness, migraines and headaches at the
time of period or before [11,23,29,33,34], and mitral
valve prolapse [29].
Social life symptoms Some symptoms such as inability
to carry on normal activities including work or school
were reported by patients [29]. Depressed and anxious
feelings [11], irritability or premenstrual tension syn-
drome [23], and psychoemotional distress and alexithy-
mia were also mentioned [47].
Table 1 A summary of overview/commentary papers on clinical symptoms and signs
Author(s) [Ref.] Year Results for symptoms Results for signs
Valle [14] 2002 Pelvic pain that often is worse just before and during menstruation,
hypermenorrhea, premenstrual staining, dyspareunia, suprapubic pain, dysuria,
hematuria, painful defecation (dyschezia), lower back pain.
Local tenderness in cul de sac or uterosacral ligaments, adnexal enlargement or
tenderness, pelvic masses.
Spaczynski and Duleba. [15] 2003 Chronic pelvic pain consists of dysmenorrhea, intermenstrual pain, and
dyspareunia.
Bluish implants typical of endometriosis or red, hypertrophic lesions bleeding on
contact, usually in the posterior fornix. lateral cervical displacement, cervical
stenosis. Retroversion, decreased or absent mobility of uterus and tenderness.
Tender masses, nodules, and fibrosis appreciated on palpation of the upper vagina,
cul-de-sac, uterosacral ligaments, or rectovaginal septum.
Kennedy et al. [16] 2005 Severe dysmenorrhea, deep dyspareunia, chronic pelvic pain, ovulation pain,
cyclical or perimenstrual symptoms (e.g. bowel or bladder associated) with or
without abnormal bleeding, infertility and chronic fatigue.
Pelvic tenderness, a fixed retroverted uterus, tender uterosacral ligaments or
enlarged ovaries on examination. The diagnosis is more certain if deeply
infiltrating nodules are found on the uterosacral ligaments or in the pouch of
Douglas, and/or visible lesions are seen in the vagina or on the cervix. The
findings may, however, be normal.
Mounsey et al. [17] 2006 Pelvic pain, back pain, dyspareunia, dysmenorrhea loin pain, dyschezia, pain with
micturition and infertility.
Tender nodules in the posterior vaginal fornix, uterine motion tenderness, a
fixed and retroverted uterus, or tender adnexal masses.
Denny and Mann. [18] 2007 Pain around menstruation, dyspareunia, dyschezia, cyclical dysuria and extreme
fatigue.
Not discussed.
Amer [19] 2008 Dysmenorrhoea, dyschezia, hematochezia, dysurea, haematurea, dyspareunia,
chronic pelvic pain, heavy and/or irregular periods, premenstrual spotting,
infertility.
Tenderness on cervical movement, thickening and tenderness of the uterosacral
ligaments, fullness or mass in the pouch of Douglas (POD), fixation and
retroversion of the uterus, rectovaginal nodule. Adnexal (or even a pelvi-
abdominal) mass in women with large endometriomas.
Luisi et al. [2] 2009 Severe dysmenorrhea, deep dyspareunia, chronic pelvic pain, ovulation pain,
cyclical or perimenstrual symptoms with or without abnormal bleeding,
infertility and chronic fatigue.
Not discussed.
Giudice. [20] 2010 Chronic pelvic pain (lasting ≥6 months), dysmenorrhea, dyspareunia, deep
pelvic pain, and lower abdominal pain with or without back and loin pain. The
pain can be continuous, and it can be dull, throbbing, or sharp, and
exacerbated by physical activity. Bladder- and bowel associated symptoms
(nausea, distention, and early satiety) are typically cyclic. Burning or hypersensi-
tivity symptoms that are suggestive of a neuropathic component (infrequently).
A pelvic mass, immobile pelvic organs, and rectovaginal nodules.
Altman and Wolcyzk. [21] 2010 Chronic pelvic pain, dysmenorrhea, dyspareunia, infertility, back pain, dyschezia,
rectal pain, diarrhea, constipation, dysuria, hematuria, infertility, chronic fatigue
and psychosocial stressors.
Palpable tender nodules in the cul-de-sac or uterosacral ligaments; localized
tenderness in the cul-desac, uterosacral ligaments, or rectovaginal septum; pain
with uterine movement; enlarged or tender adnexal masses; and fixation of adnexa
or uterus in a retroverted position. Red, blue, or hemorrhagic nodules may also be
visualized on the external genitalia, vagina, or cervix.
Okeke and Ikeako. [9] 2011 Dysmenorrhea, dyspareunia, menorrhagia and infertility. Not discussed.
Koninckx et al. [22] 2012 Hypogastric pain, especially dysmenorrhea, deep dyspareunia, severe chronic
pain, mictalgia, and dyschezia.
Not discussed.
Acién and Velasco [23] 2013 Dysmenorrhea (during and at the end of menstruation), deep dyspareunia,
chronic pelvic pain, and infertility premenstrual spotting for 2–4 days, headache,
irritability, or premenstrual tension syndrome.
Not discussed.
Carneiro M M et al. [24] 2013 Dysmenorrhea, dyspareunia, dyschezia, gastrointestinal symptoms, chronic pelvic
pain, infertility.
Pelvic tenderness, a fixed retroverted uterus, tender uterosacral ligaments or
enlarged ovaries, uterosacral nodularity.














Table 1 A summary of overview/commentary papers on clinical symptoms and signs (Continued)
Mehedintu et al. [26] 2014 Severe dysmenorrhea, non-cyclical chronic pelvic pain, dysfunctional uterine
bleeding, infertility, dyspareunia, painful defecation during menstruation, urinary
tract symptoms and gastrointestinal symptoms
Not discussed.
Bhattacharjee et al. [27] 2014 Dysmenorrhea, deep dyspareunia, infertility, abnormal uterine bleeding, non-cyclic
pain, menstrual cycle abnormalities, constipation, chronic fatigue, heavy or long
uncontrollable menstrual periods with small or large blood clots, gastrointestinal
problems including diarrhea, bloating and painful defecation, extreme pain in legs
and thighs, back pain, mild to extreme pain during intercourse, pain from
adhesions which may bind an ovary to the side of the pelvic wall, or they may
extend between the bladder and the bowel, uterus, extreme pain with or without
the presence of menses, premenstrual spotting, mild to severe fever, headaches,
depression, hypoglycemia and anxiety.
Non-specific pelvic tenderness, localized tenderness in the pouch of Douglas,
thickened nodular uterosacral ligaments, fixed retroverted uterus, palpable fixed
cystic adnexal mass or an obliterated pouch of Douglas, masses, fixity of organs,
displacements of cervix & presence of nodules in the rectovaginal pouch or
uterosacral ligaments, nodularity or tenderness in the uterosacral ligament,
bluish or red powder burn lesions may be seen in the cervix or posterior fornix
of the vagina (which may be tender or bleed on touch), bluish nodules in the
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joint pain and leg pain [11].
Other symptoms Patients reported suffering from chronic
fatigue, exhaustion, low energy and low-grade fever
[2,11,16,18,21,29]. Women also reported burning or hyper-
sensitivity, symptoms that were suggestive of a neuropathic
component [20]. Mictalgia was also mentioned [22]. Previ-
ous surgery for endometriosis also was found a consider-
able factor [31,42]. The findings are presented in Table 2.
Clinical diagnosis by signs obtained from physical
examination
Clinical signs of the disease that identified by physical
examination (pelvic examination by inspection and pal-
pation) included a broad range of signs. External geni-
talia and the vaginal surface were usually unremarkable
[15]. Findings of physical examination are listed as
follows:
External genitalia Visible red, blue, or hemorrhagic
nodules on the external genitalia [21].
Vagina Visible red, blue, or hemorrhagic nodules on the
vagina, and tender masses, nodules, and fibrosis on pal-
pation of the upper vagina [8,15-17,21].
Cervix Visible lesions on the cervix, tenderness on cer-
vical movement, lateral cervical displacement, and cer-
vical stenosis [15,16,19,21,37].
Uterus A fixed (decreased or absent mobility) and retro-
verted uterus, and uterine motion tenderness in pelvic
examination [8,15-17,19,21,24].
Adnexa Tender or fixed adnexal masses resulting from
endometriomas, adnexal enlargement, and pelvic masses
[8,14,17,19,21].
Posterior vaginal fornix Tender nodules in the poster-
ior vaginal fornix, bluish implants typical of endometri-
osis or red, hypertrophic lesions bleeding on contact
[15,17].
Pouch of Douglas Fullness or mass or nodularity or
pain in the pouch of Douglas, local tenderness or palp-
able tender nodules in cul de sac [8,14,16,19,30].
Rectovaginal septum Tender masses, nodules, and fi-
brosis of the rectovaginal septum [15,19-21,37].
Uterosacral ligament Thickening, pain or tenderness or
nodularity in uterosacral ligament [8,14-16,19,21,24,30].The most reported signs included changes in uterus,
cervix, adnexa and uterosacral ligament palpation. The
findings are shown in Table 2.
Clinical diagnosis by risk factors obtained from history
taking
Although it was reported that the following risk factors
alone are not enough, they could potentially direct phy-
sicians toward clinical diagnosis of pelvic endometriosis.
All risk factors are presented in Table 3.
Risk factors related to menstrual periods Included
early menarche (before age 11–13) or late menarche
(menarche at ≥14 y) [12,15,20,33,39,54], short menstrual
cycle (≤27 days) [15,17,20,32,58], longer menstrual flow
(≥7 days) [15,30], and spotting before onset of menses
[11,15,19,23,29,51]. Late menopause [20], early history of
dysmenorrhea [12], obstruction of menstrual outflow for
example mullerian anomalies and use of pads and tam-
pons were other risk factors [17,20].
Risk factors related to patients’ characteristics Patients
who were taller, thinner and had lower body mass
index, red hair [1,15,39,40,43] and dysplastic nevi [15]
were found to be more prone to pelvic endometriosis.
Higher education was considered as another risk fac-
tor [18]. Rh-negativity [46], severe teenage acne [48]
and blue eye color [49] were also mentioned as risk
factors for pelvic endometriosis.
Risk factors related to obstetrics and gynecologic
history These included not having a history of preg-
nancy or delivery, [15,39-42], late initiation of sexual ac-
tivity (≥21 y) and never used OCPs [17,39].
Risk factors related to family history Included family
history of endometriosis for example mother or sister
[15,17,36,38,44]. The relative risk of endometriosis in
female siblings was found to be 5.7 [42].
Risk factors related to nutrition Consumption of red
meat and trans fats were associated with an increased
risk of endometriosis, and eating fruits, green vegetables,
and omega-3 long-chain fatty acids were associated with
a decreased risk [20].
Risk factors related to embryonic factors Included
exposure to diethylstilbestrol in utero and low birth
weight [20].
Risk factors related to patient’s habits Consumption
of one or more alcoholic drinks per week [17,39,40,55].
Table 2 Main diagnostic symptoms and signs obtained from history taking and physical examination respectively
Author(s) [Ref.] Year Study design Sample
size
Findings
Eskenazi et al. [8] 2001 Prospective study (study sample);
retrospective record review (test
sample).
90 Symptoms: Dysmenorrhea, pelvic pain, dyspareunia and infertility.
Signs: Uterosacral ligament scarring, nodularity, or pain, nodularity
or pain in the pouch of Douglas, vaginal endometriotic lesions,
painful or fixed adnexal masses, and fixed uterus or pain on
movement of uterus in pelvic examination.
Chapron et al. [28] 2002 Retrospective analysis 160 Signs: Endometriotic lesions seen in speculum examination and
classic, painful, spheric nodule or painful induration in palpation.
Ballweg L M [29] 2004 Cross sectional 7000 Symptoms: Fatigue, exhaustion, low energy, numerous
gastrointestinal symptoms, abdominal bloating, diarrhea, painful
bowel movements or other intestinal upset, nausea and
stomach upset at time of period, a wide range of allergies and
allergic disease; heavy or irregular bleeding, pain with or after
sex, dizziness and headaches at the time of the period and
other debilitating symptoms (unable to carry on normal
activities, including work or school), in addition to the classic
symptom of pain (dysmenorrhea, pain with or after sex
(dyspareunia). Lower back pain, pain in the rectum, irregular
bleeding, low resistance to infection, infertility, premenstrual
spotting, low-grade fever, Pain related to
urination, candidiasis, mid cycle bleeding, mitral valve prolapse.
Lemaire. [11] 2004 Descriptive, cross-sectional
correlational study.
298 Symptoms: Menstrual cramping, fatigue, lower back pain, heavy
menstrual flow, non-period pelvic pain, diarrhea with period,
allergy, urinary frequency, pain with intercourse, depressed
feelings, constipation, muscle/bone pain, headache, anxious
feelings, joint pain, leg pain, spotting between/before periods,
rectal pain, urinary infection, yeast infection.
Cheewadhanaraks et al. [30] 2004 Prospective study 116 Signs: Tenderness and/or nodularity of the cul-de-sac and/or
uterosacral ligament(s).
Chapron et al. [31] 2005 Cross sectional 134 Symptoms: Painful defecation during menses, severe dyspareunia,
pain other than noncyclic, and previous surgery for endometriosis.
Ballard and Mangubat. [32] 2007 National community-based
case–control
27715 Symptoms: Pelvic pain and dysmenorrhea, dyspareunia,
menorrhagia, urinary symptoms (dysuria, cystitis, and urinary tract
infections), irritable bowel syndrome (IBS), pelvic inflammatory
disease and ovarian cysts.
Flores et al. [33] 2008 Cross sectional 1285 Symptoms: Dysmenorrhea, dyspareunia, conceiving problems,
chronic pelvic pain, ovarian cysts, migraines, and gynecological
infections.
Greene et al. [34] 2009 Cross-sectional 4334 Symptoms: Pelvic pain, menstrual pain, ovulatory and
nonmenstrual pain, lifetime presence of all three pain types, heavy
bleeding, infertility, bowel symptoms, urinary symptoms, pain with
urination, nausea/stomach upset or dizziness/headache during
menses.
Ballard et al. [35] 2010 Prospective questionnaire-based 185 Symptoms: Throbbing pain and dyschezia.
Abbas et al. [7] 2012 Cohort 62,323 Symptoms: Dysmenorrhea, dyspareunia, intermenstrual pain,
menorrhagia, ovarian cysts, pelvic pain, postcoital bleeding,
infertility, irritable bowel syndrome, pelvic inflammatory disease.
Nnoaham et al. [36] 2012 Prospective, observational, two-
phase study
1,396 Symptoms: Dysmenorrhea, dyspareunia, pelvic pain, Bowel/urinary
symptoms, infertility, family history.
Hadisaputra. [37] 2013 Cross sectional 80 Symptoms: Infertility, dysmenorrhea, dyspareunia and chronic
pelvic pain. Signs: Rectovaginal nodule and cervical tenderness.
Cavaggioni et al. [47] 2014 Case- control 80 Symptoms: Mood and anxiety disorders, obsessive-compulsive
malfunction, depression, alexithymia.
Heitmann et al. [51] 2014 Retrospective cohort study 80 Symptom: Premenstrual spotting of≥ _2 days
Walch et al. [52] 2014 Prospective, controlled clinical
trial
102 Symptom: Cyclic leg pain
Barbosa et al. [53] 2014 Cross sectional 387 Symptom: Dysmenorrhea was the only clinical symptom
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Table 3 Risk factors or characteristics of endometriosis patients
Author(s) [Ref.] Year Study design Sample size Findings
Kashima et al. [38] 2004 Case–control 623 Familial tendency.
Hediger et al. [39] 2005 Cohort study 48 Taller, thinner and lower body mass index, late maturers
(menarche at ≥14 y) and late to initiate sexual activity (≥21
y), less likely to be gravid, parous, and a current smoker.
Flores et al. [33] 2008 Cross-sectional 1285 Longer length of menses, earlier menarche and shorter
cycle length.
Parazzini et al. [40] 2008 Case–control 672 More education, lower body mass index, never smoking
and null parity.
Sinaii et al. [41] 2008 Cross-sectional 940 Pelvic pain, subfertility.
Yi et al. [1] 2009 Retrospective review of
clinical records
481 Lower BMI.
Bazot et al. [42] 2009 Retrospective
longitudinal study
92 Infertility, previous surgery for endometriosis, nulliparity,
noncyclic chronic pelvic pain, dysmenorrhea, deep
dyspareunia, painful defecation, dysuria and asthenia.
Treloar et al. [12] 2010 Case–control 268 Early menarche and early history of dysmenorrhea.
Lafay et al. [43] 2011 Case–control 476 Lower body mass index.
Chapron et al. [44] 2011 Cross-sectional 229 Positive family history, more absenteeism from school
during menstruation, OC pill use for treating severe
primary dysmenorrhea.
Nnoaham et al. [54] 2012 Systematic review and
meta-analysis of case–
control studies.
18 articles Early menarche
Peterson et al. [45] 2013 Cohort 626 Infertility history, dysmenorrhea and pelvic pain.
Parazzini et al. [55] 2013 Metaanalysis 15 articles Alcohol consumption
Borghese et al. [46] 2014 cross-sectional 663 Rhesus negativity
Xie et al. [48] 2014 prospective cohort
study
88 623 Severe teenage acne.
Vercellini et al. [49] 2014 Case–control 771 Blue eye color
Tu et al. [50] 2014 Prospective cohort
study
9,585 Prior OCP use in nulliparous women
Bungum et al. [56] 2014 Systematic review 5 articles Increased risk of allergic disorders (asthma, hay fever/
allergic rhinitis of the sinus, eczema, food allergy, allergy to
either pollen, dust, trees, paint, grasses, cigarette smoke,
perfumes/fragrances, cleaning products, foods or
environmental chemicals)
Bonocher et al. [57] 2014 Systematic review 6 articles Inconclusiveness regarding the benefits of physical
exercise as a risk factor
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risk of the disease [15].
However, prolonged lactation, multiple pregnancies,
the combined oral contraceptive, smoking and exercise
are reported as protective factors [20]. The most risk
factors were related to menstrual periods, patients’ char-
acteristics and family history.
Discussion
The emphasis of this review was on several aspects of
the clinical diagnosis of pelvic endometriosis. All factors
that could have been of any help in clinical diagnosis of
the disease were reviewed and classified. These findings
divided in three main categories. Moreover this article
showed that there were many more symptoms than have
traditionally associated with endometriosis.Usefulness of clinical signs and symptoms in the diag-
nosis of pelvic endometriosis in women who present
with infertility was shown in some studies [17]. In
addition, it has been reported that some symptoms had
greater predictive value. The most commonly reported
symptoms leading to a diagnosis were dysmenorrhea
and pelvic pain. Treloar et al. reported that dysmenor-
rhea was associated with a 2.5-fold increased risk of sub-
sequent endometriosis [12]. Pelvic pain was reported by
all patients in a study by Greene et al. [34]. Among the
other symptoms leading to a diagnosis, subfertility and
an ovarian mass were more commonly reported in
stages 3–4, whereas dyspareunia was more common in
stages 1–2 [41]. Women with endometriosis were 9
times as likely to report dyspareunia as compared to a
control group [32]. In Nnoaham et al. study painful
Riazi et al. BMC Women's Health  (2015) 15:39 Page 9 of 12defecation during menstruation and a history of be-
nign ovarian cysts strongly predicted any stages of the
disease. The stage III and IV disease was predicted
with good accuracy based on symptom-based model.
They used several variables in their model including
indications for surgery, menstrual history, dysmenor-
rhea, dyspareunia, pelvic pain, bowel/urinary symp-
toms, pregnancy/infertility history, personal characteristics
and family history [36].
Chapron et al. showed that variables such as painful
defecation during menses, severe dyspareunia, pain
other than noncyclic, and previous surgery were consid-
ered as independent predictors for posterior deep infil-
trating endometriosis. They showed a diagnostic model
that used two independent predictors: painful defecation
during menses and severe dyspareunia. The sensitivity of
this model for diagnosing posterior deep infiltrating
endometriosis was 74.5% and its specificity was 68.7%.
They concluded that standardized evaluation of pain-
ful symptoms is useful for screening the disease [31].
Pelvic inflammatory disease and ovarian cysts were 6
and 12 times as likely to be made in women with
endometriosis [14].
Although no test provides strong evidence for the
presence of endometriosis, the symptom of uterosacral
pain had the highest positive likelihood ratio for the
diagnosis of endometriosis [20]. In addition to the classic
symptom of pain, other symptoms such as fatigue, ex-
haustion, low energy, gastrointestinal problems, abdom-
inal bloating, and a range of allergic diseases also
showed a positive association with endometriosis. These
are usually dismissed because they are not widely
known. These symptoms are very important. A study by
Lemaire showed that the three symptoms with highest
total symptom distress were fatigue or weariness, men-
strual cramping and nonperiodic pelvic pain [11].
Women with endometriosis were twice as likely to re-
port urinary symptoms such as dysuria, cystitis, and
urinary tract infections compared with control group
[14]. Sinaii et al. did not report any significant relation-
ship between endometriosis and regular, vigorous exer-
cise, regular use of talc as body powder and cigarette
smoking [43], but other studies have found a significant
association between smoking and endometriosis [40]. In
Hediger study, patients were more likely to be late ma-
turers (menarche at ≥14 y) [39] while in other studies
early menarche was often cited as a risk factor for endo-
metriosis [12]. In Parazzini study age at menarche and
lifelong type of menstrual cycles were not related to the
risk of deep or pelvic and ovarian endometriosis [40]. So
it seems that further studies are needed to clarify this
relationship.
The risk of the disease raised by advancing age
within the reproductive years, peaking among womenaged 40–44 years [58]. The findings of the Ballweg’s
study indicated that the disease was more severe with
an early age of onset and thus it is necessary to pay
more attention to girls suffering from menstrual pain
[29]. Most studies have shown a significant relation-
ship between endometriosis and length of menstrual
cycle, menstrual volume, occurrence of irregular men-
strual periods, recent pelvic pain or dyspareunia ex-
cept one [39] which may be attributed to the small
sample size of the study. In the Flores’s study among
Puerto Rican women the diagnosis of endometriosis
was significantly associated with dysmenorrhea, dys-
pareunia, and chronic pelvic pain, but not with men-
strual cycle characteristics [33]. This was probably
due to their study on Hispanic population. In Treloar
et al. study no association was found between endo-
metriosis and duration of natural menstruation, heavi-
ness of flow, type of sanitary protection used and
history of sexual intercourse during menstruation
which may be due to recall bias or small size of con-
trol group [12]. Ballard and Mangubat showed that
menorrhagia in women with endometriosis was 5
times higher that controls [32].
Lafay et al. showed that patients with the lowest BMI
(≤18.5) were at a higher risk of deep infiltrating endo-
metriosis. BMI was significantly lower in deep infiltrat-
ing endometriosis and ovarian endometrioma patients
but not for the superficial endometriosis patients [43]. In
Yi et al. study, women with advanced-stage endometri-
osis had lower BMI than those with minimal or mild dis-
ease, and BMI was significantly associated with disease
severity [1]. These findings are in line with other studies
[39,40], but in Kennedy study the risk of the disease was
increased for women with greater peripheral fat [58].
Borghese et al. showed that Rh-negative women were
twice as likely to develop endometriosis. [46]. However,
there is controversy about the relationship between
blood group and endometriosis [46,59,60] and further
investigation is needed to determine the role of blood
groups in the development of endometriosis. In a study
by Xie et al. it was reported that women who had severe
teenage acne had a 20% increased risk of endometriosis.
Probable mechanisms for such observation might be due
to genetic factors, sex hormones including estrogens and
immune malfunction [48]. Blue eye color also was an-
other factor. It is argued that perhaps genetic factors,
and vitamin D deficiency due to photo-sensitivity might
lead to a relationship between eye color and endometri-
osis [49]. Several studies have shown that the risk of
allergic disease could be increased with endometrio-
sis [56].
In Kashima et al. study the relative risk of endometri-
osis in female siblings of patients was 5.7 [38], which
were consistent with other findings [17]. These findings
Riazi et al. BMC Women's Health  (2015) 15:39 Page 10 of 12propose a familial tendency and a genetic factor for
endometriosis.
Endometriosis occurs more commonly in middle-aged,
upper class, ambitious, white women. This may occur due
to greater access to medical care and diagnostic tests such
as laparoscopy in these women [58]. Several studies have
shown different results about the relationship between
physical activity and endometriosis so there is inconclu-
siveness regarding the benefits of physical exercise as a
risk factor for the disease [57].
Two important signs must be considered: deep dyspar-
eunia and nodules in the pouch of Douglas [23]. Findings
of physical examination vary significantly with location of
endometriotic lesions. They can be seen on speculum
examination in only 14% of patients, and a classic, painful,
spheric nodule can be palpated in only 43% [28]. In Cha-
pron study a nodule was found in 80% of patients with va-
ginal endometriosis, this rate dropped to only 35% and
33% in those with deep infiltrating endometriosis of the
digestive tract and uterosacral ligaments, respectively [28].
High locations of deep infiltrating endometriosis lesions at
the level of uterosacral ligaments, bottom of the pouch of
Douglas and upper one-third of the posterior vaginal wall
explain why results of routine clinical examination are so
poor. Cheewadhanaraks showed a positive predictive value
of tenderness and/or nodularity of the cul-de-sac and/or
uterosacral ligament(s) in diagnosis of the endometriosis
[30]. In Howard study no findings on physical examin-
ation, including cervical deviation, cervical tenderness, or
paracervical tenderness were predictive for the disease
[61] but in Bazot et al. study the sensitivity of physical
examination was 73.5% for uterosacral ligament endomet-
riosis, 50% for vaginal endometriosis and 46% for intes-
tinal endometriosis. The accuracy of physical examination
is higher during menstruation [42].
Eskenazi et al. reported that ovarian endometriosis,
but not nonovarian endometriosis, could be reliably pre-
dicted with noninvasive procedures. They used history,
pain reports, physical examination and ultrasound for
prediction and found that these procedures have moder-
ate success in predicting a surgical diagnosis of endo-
metriosis [8].
Attempts to diagnose women using symptoms, clinical
findings or ultrasonography had disappointing findings
except, possibly, for ovarian endometriosis in Hediger
et al. study [39]. Women with endometriosis experience
significantly more gynecological, urological and bowel
symptoms than women without endometriosis [32], and
that the risk of endometriosis increases in women with
endometriosis-related symptoms [7].
Conclusion
Clinical diagnosis of pelvic endometriosis is difficult.
Thus considerable efforts are needed to improve theclinical diagnosis of pelvic endometriosis because it
could help to prioritize women for further investigation
and contribute to its early diagnosis. However, this re-
view provides integrated findings from the literature
containing issues related to signs, symptoms and risk
factors. The findings suggest that better diagnosis of pel-
vic endometriosis need a careful and comprehensive in-
vestigation about risk factors during history taking and
clinical visits. Perhaps every notes during this period by
clinicians and midwifes might lead to timely diagnosis
and treatment. Further studies with much more focus
on signs and symptoms of the disease are recommended
for clarifying the present contradictions.
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